In the November issue published a decade ago, Genome Technology profiled Michael Pavia — then-chief technology officer of Millennium Pharmaceuticals — and examined his efforts to accelerate drug development. At the time, Pavia had recently hired Helen Han, a former Toyota employee who had no knowledge of the pharmaceutical industry, hoping she would bring a fresh perspective to the firm. Together, he and Han looked to improve Millennium's chemical optimization operations and clinical trials with custom microarrays, which the firm began to build in-house.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.